1. IDF21-0686 Indirect treatment comparison of efficacy and safety of insulin glargine 300 U/mL with once-daily-insulin premix in T2DM. (April 2022) Authors: Ritzel, R.; Ghosh, S.; Emral, R.; Malek, R.; Malik, R.; Zeng, L.; Huang, Y.; Mabunay, M.A.; Landgraf, W.; Guyot, P.; Schenk, E.; Pushkarna, D. Journal: Diabetes research and clinical practice Issue: Volume 186:Supplement 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Patient‐level meta‐analysis of the EDITION 1, 2 and 3 studies: glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus glargine 100 U/ml in people with type 2 diabetes. Issue 9 (16th June 2015) Authors: Ritzel, R.; Roussel, R.; Bolli, G. B.; Vinet, L.; Brulle‐Wohlhueter, C.; Glezer, S.; Yki‐Järvinen, H. Journal: Diabetes, obesity & metabolism Issue: Volume 17:Issue 9(2015:Sep.) Page Start: 859 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗